AXLE PEEK INTERSPINOUS FUSION SYSTEM

K112592 · X-Spine Systems, Inc. · KWP · Dec 5, 2011 · Orthopedic

Device Facts

Record IDK112592
Device NameAXLE PEEK INTERSPINOUS FUSION SYSTEM
ApplicantX-Spine Systems, Inc.
Product CodeKWP · Orthopedic
Decision DateDec 5, 2011
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3050
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Axle PEEK Interspinous Fusion System is a posterior, non-pedicle supplemental fixation device, intended for use at a single level in the non-cervical spine (T1-S1 inclusive). It is intended for plate fixation/attachment to spinous processes for the purpose of achieving supplemental fusion in the following conditions: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); and/or tumor. The Axle PEEK Interspinous Fusion System is intended for use with bone graft material, and not for stand-alone use.

Device Story

Posterior, non-pedicle supplemental fixation system; provides stabilization of spinous processes to support fusion. Components include titanium alloy plates and PEEK-Optima LT1 inserts. Assembled in various configurations to accommodate patient anatomy and pathology. Used by surgeons in clinical settings to treat degenerative disc disease, spondylolisthesis, trauma, or tumor. Requires concurrent use of bone graft material. Implanted via surgical procedure; provides mechanical stabilization to facilitate bone fusion; benefits patient by supporting spinal stability.

Clinical Evidence

Bench testing only. Biomechanical testing performed per ASTM F1717, including static compression bending, static torsion, and fatigue compression bending, to demonstrate performance equivalence to predicate.

Technological Characteristics

Spinal interlaminal fixation orthosis. Materials: Titanium alloy (ASTM F136) plates and PEEK-Optima LT1 inserts. Mechanical stabilization via spinous process fixation. Non-sterile, requires cleaning. No software or electronic components.

Indications for Use

Indicated for patients requiring supplemental spinal fusion at a single level in the non-cervical spine (T1-S1) due to degenerative disc disease, spondylolisthesis, trauma (fracture/dislocation), or tumor. Must be used with bone graft; not for stand-alone use.

Regulatory Classification

Identification

A spinal interlaminal fixation orthosis is a device intended to be implanted made of an alloy, such as stainless steel, that consists of various hooks and a posteriorly placed compression or distraction rod. The device is implanted, usually across three adjacent vertebrae, to straighten and immobilize the spine to allow bone grafts to unite and fuse the vertebrae together. The device is used primarily in the treatment of scoliosis (a lateral curvature of the spine), but it also may be used in the treatment of fracture or dislocation of the spine, grades 3 and 4 of spondylolisthesis (a dislocation of the spinal column), and lower back syndrome.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ 2112592 DEC - 5 2011 # 510(k) Summary ## ADMINISTRATIVE INFORMATION | Manufacturer Name: | X-spine Systems, Inc. | |--------------------|--------------------------| | | 452 Alexandersville Rd. | | | Miamisburg, OH 45342 | | | Telephone (937) 847-8400 | | | FAX (937) 847-8410 | | Official Contact: | David Kirschman, MD | | | Chief Medical Officer | | Date Prepared: | September 6, 2011 | DEVICE NAME | Trade/Proprietary Name: | Axle PEEK Interspinous Fusion System | |-------------------------|---------------------------------------| | Common Name(s): | Interspinous Process Fixation System | | Classification Name(s): | Spinal Interlaminal Fixation Orthosis | | Device Class: | Class II | \$888.3050 KWP ## ESTABLISHMENT REGISTRATION NUMBER X-spine Systems, Inc. has submitted an Establishment Registration to FDA. The Establishment Registration number is 3005031160. The owner/operator number for X-spine Systems, Inc. is 9063903. ## INTENDED USE Classification(s): Product Codes(s): The Axle PEEK Interspinous Fusion System is a posterior, non-pedicle supplemental fixation device, intended for use at a single level in the non-cervical spine (T1-S1 inclusive). It is intended for plate fixation/attachment to spinous processes for the purpose of achieving supplemental fusion in the following conditions: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); and/or tumor. The Axle PEEK Interspinous Fusion System is intended for use with bone graft material, and not for stand-alone use. {1}------------------------------------------------ ## DEVICE DESCRIPTION The Axle PEEK Interspinous Fusion System consists of plates and inserts of various sizes that are used to provide supplemental stabilization of the spinous processes to support fusion. The system components can be assembled in a variety of configurations so that adaptations can be made to take into account pathology and individual patient anatomy. The implant components are provided clean and non-sterile. The plate components of the device are made from titanium alloy per ASTM F136 and the insert components are made from polyetheretherketone (Invibio PEEK-Optima LT1). ## COMPARISON TO CLEARED DEVICE X-spine Systems, Inc. has submitted information to demonstrate that, for the purposes of FDA's regulation of medical devices, the Axie PEEK Interspinous Fusion System substantially meets the performance criteria established by the cleared parent device. The modified device is substantially equivalent to predicate device based on a comparison including the following characteristics: - . FDA Product Code - . Intended Uses - . Surgical Approach - . Anatomical Region - . Product Dimensions - . Mechanical Performance ## PERFORMANCE DATA The implant components were tested using the following standards: ASTM F1717 – Standard Test Methods for Spinal Implant Constructs in a Vertebrectomy Model - Static Compression Bending . - . Static Torsion - Fatigue Compression Bending . In conclusion, biomechanical testing results indicate that the Axle PEEK Interspinous Fusion System is substantially equivalent to predicate device performance and is capable of safely and effectively performing in accordance with its intended use. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird symbol, with three curved lines representing its wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the bird symbol. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 DEC - 5 2011 X-spine Systems, Inc. % David Kirschman, MD Chief Medical Officer 452 Alexandersville Road Miamisburg, Ohio 45342 Re: K112592 Trade/Device Name: Axle PEEK Interspinous Fusion System Regulation Number: 21 CFR 888.3050 Regulation Name: Spinal interlaminal fixation orthosis Regulatory Class: Class II Product Code: KWP Dated: November 04, 2011 Received: November 07, 2011 Dear Dr. Kirschman: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act {3}------------------------------------------------ Page 2 - David Kirschman, MD or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ #### Indications for Use #### 510(k) Number (if known): K112592 Device Name: Axle PEEK Interspinous Fusion System Indications for Use: The Axle PEEK Interspinous Fusion System is a posterior, non-pedicle supplemental fixation device, intended for use at a single level in the non-cervical spine (T1-S1 inclusive). It is intended for plate fixation/attachment to spinous processes for the purpose of achieving supplemental fusion in the following conditions: degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies); spondylolisthesis; trauma (i.e., fracture or dislocation); and/or tumor. The Axle PEEK Interspinous Fusion System is intended for use with bone graft material, and not for standalone use. Prescription Use __ × (Part 21 CFR 801 Subpart D) Over-The-Counter Use AND/OR (21 CFR 801 Subpart C) #### (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) 17 1.4 21 0.80 (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices KI12592 510(k) Number_
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%